Obesity Inhibits Innate Lung Bactericidal Functions

NIH RePORTER · NIH · F31 · $39,112 · view on reporter.nih.gov ↗

Abstract

Project Abstract Obesity is a major global public health concern. Worldwide, 39% of the population is overweight and 13% of the population is obese. Obesity contributes to many other diseases, such as heart disease, stroke, some cancers, and notably, type 2 diabetes (T2D). Currently, 425 million people globally have been diagnosed with T2D and this number is expected to grow to over 600 million people by 2050. Although T2D itself is a non-communicable disease, many patients with diabetes are more susceptible to microbial infections and exhibit a higher burden of disease. Although obese animals have an increased production of myeloid cells, previous work from our labs has shown that a failure to heal diabetic wounds corresponds to elevated levels of prostaglandin E2 (PGE2) in the inflammatory macrophages that are recruited to the wound. Furthermore, past studies from our lab have demonstrated that PGE2 signaling can impair the innate immune functions of macrophages. Therefore, we hypothesized that diabetic obese mice would be more susceptible to a respiratory Pseudomonas aeruginosa strain PA01 infection due to impaired function of lung resident and recruited macrophages. Preliminary studies demonstrate that obese diabetic mice do have an increased P. aeruginosa burden in the lung 24 hours after infection. Additionally, we have determined that naïve obese diabetic mice have an increase in lung neutrophils compared to lean mice, however, after infection with P. aeruginosa, these mice have a decrease in neutrophils compared to lean mice. This suggests that obese mice have a defect in neutrophil recruitment during infection. Additionally, neutrophil function assays show that neutrophils from obese diabetic mice have a defect in killing P. aeruginosa. These observations drive this proposal which will test the hypothesis that obese diabetic mice have not only a defect in innate immune cell recruitment, but also a defect in innate immune cell function during bacterial pneumonia. This hypothesis will be tested through two specific aims: Aim 1) determine the functional defects in alveolar macrophages during P. aeruginosa infection and Aim 2) determine the bacterial clearance and recruitment defects in neutrophils during P. aeruginosa infection. Throughout these aims, we explore sex as a biological variable, as males have enhanced obesity-induced inflammation compared to females. Experiments for these aims will be completed with the use of a murine diet induced obesity model, cells derived from these mice, and human cells derived from discarded blood samples from patients with and without T2D. The results from these innovative studies may inform treatments to improve outcomes from bacterial pneumonia in patients with T2D. Completion of this proposal will also allow for the applicant to receive rigorous training in experimental design, implementation, and interpretation that will help her become a successful, independent scientist.

Key facts

NIH application ID
10462029
Project number
1F31HL163865-01
Recipient
UNIVERSITY OF MICHIGAN AT ANN ARBOR
Principal Investigator
Gabrielle Entrup
Activity code
F31
Funding institute
NIH
Fiscal year
2022
Award amount
$39,112
Award type
1
Project period
2022-07-01 → 2025-06-30